• 'Cobalt settles Imitrex litigation with Glaxo (Pharmaceutical Business Review)
  Cobalt Laboratories has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GSKs Imitrex tablets.



• 'Spectrum, GSK settle Imitrex patent litigation (PharmaBiz)
  Spectrum Pharmaceuticals, Inc. has settled a patent litigation with GlaxoSmithKline relating to sumatriptan injection, the generic version of GlaxoSmithKline's Imitrex Injection.



• 'Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation (FinanzNachrichten)
  IRVINE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, ( Nachrichten ) Inc. today announced that it has settled a patent litigation with GlaxoSmithKline ( Nachrichten / Aktienkurs ) relating to sumatriptan injection, the generic version of GlaxoSmithKline's Imitrex Injection.



• 'Cobalt Announces Settlement of Imitrex(R) Litigation With GlaxoSmithKline (PR Newswire via Yahoo! Finance)
  Cobalt Laboratories Inc. , on behalf of its affiliate Cobalt Pharmaceuticals Inc., announced today that is has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline's Imitrex® tablets.



• 'GSK Brands Shift to IPG (AdWeek)
  NEW YORK Three Interpublic Group shops have landed ad duties on GlaxoSmithKline brands in five categories that previously were split between WPP Group agencies Grey Healthcare and Thomas Ferguson Associates, sources said.

Back to Imitrex News Archive

Imitrex